Enliven therapeutics to present at the td cowen 45th annual health care conference

Boulder, colo. , feb. 25, 2025 /prnewswire/ -- enliven therapeutics, inc. (enliven or the company) (nasdaq: elvn), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that management will participate in a fireside chat at the td cowen 45th annual health care conference on tuesday, march 4, 2025, at 10:30 a.m.
COWN Ratings Summary
COWN Quant Ranking